Medtronic has a green light from regulators to begin studies that could lead to automated insulin delivery. A feature in the company's insulin pumps stops sending insulin when blood sugar levels get too low.
Minnesota-based Medtronic to get $17M for artificial pancreas research
Fridley-based Medtronic will be getting $17 million over the next three years for an initiative aimed at stabilizing blood sugar levels in diabetics. The medical technology company announced Friday that they are getting the money from the Juvenile Diabetes Research Foundation and the Helmsley Charitable Trust to improve existing and develop new artificial pancreas technology.